Antibodies targeting PDL1 and methods of use thereof
US12077588B2 · kind B2 · utility
0Cited by
0References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 9, 2018 |
| Grant date | Sep 3, 2024 |
| Priority date | — |
| Expiry date | Oct 9, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to an isolated antibody which specifically binds human PDL 1, and pharmaceutical compositions and methods of use thereof. The present invention further relates to a nucleic acid encoding said antibody, a vector comprising said nucleic acid, a host cell comprising said nucleic acid or said vector, and a method of producing said antibody.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.